Article

Prognostic Implication of Early Minimal Residual Disease Evaluation in Patients with Chronic Myelomonocytic Leukemia

2022-03-18

Abstract excerpt

<h4>Background: </h4> This article is performed to assess the significance of minimal residual disease (MRD) after one course of therapy in patients with chronic myelomonocytic leukemia (CMML). <h4>Methods: </h4>: From January 2010 to January 2022, a total of 158 patients who were newly diagnosed with CMML were enrolled, in which 58/158 (37%) patients were conducted by multiparameter flow cytometry (FCM) assessed...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: db8a4d04-96f5-5c2e-83f9-89b4b7bbb820
DOI: 10.21203/rs.3.rs-1454975/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prognostic Implication of Early Minimal Residual Disease Evaluation in Patients with Chronic Myelomonocytic LeukemiaDOI 10.21203/rs.3.rs-1454975/v1Read

Acute Myeloid Leukemia Minimal Residual Disease Detection: The Difference from Normal Approach.Semantic proximity Read

Minimal Residual Disease Detection in Acute Lymphoblastic LeukemiaSemantic proximity Read

Prognostic and Therapeutic Implications of Measurable Residual Disease Detection Across Hematologic Malignancies: Clinical Impact on Relapse Prediction and Survival OutcomesSemantic proximity Read

Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease–Directed TherapySemantic proximity Read

Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemiaSemantic proximity Read

Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia.Semantic proximity Read

Clinical application of next-generation sequencing-based monitoring of minimal residual disease in childhood acute lymphoblastic leukemiaSemantic proximity Read

[Prognostic significance of early assessment of minimal residual disease in acute myeloid leukemia with mutated NPM1 patients].Semantic proximity Read

Measurable Residual Disease at Induction Redefines Partial Response in Acute Myeloid Leukemia and Stratifies Outcomes in Patients at Standard Risk Without NPM1 Mutations.Semantic proximity Read

Performance of a novel 8-color flow cytometry panel in the detection of minimal residual disease assessment of chronic lymphocytic leukemiaSemantic proximity Read

Minimal residual disease in acute myelogenous leukemia.Semantic proximity Read

Single-cell immune landscape of measurable residual disease in acute myeloid leukemiaSemantic proximity Read